Ortataxel

未知生产厂商

Ortataxel has been used in trials studying the treatment of Lymphoma, Lung Cancer, Glioblastoma, and Kidney Cancer.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Ortataxel has been used in trials studying the treatment of Lymphoma, Lung Cancer, Glioblastoma, and Kidney Cancer.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

SOLID FORMS OF ORTATAXEL
US 2011054015 A1申请人: INDENA SPA优先权: 2008
CN
US
4 件公开
PHARMACEUTICAL COMPOSITION CONTAINING TAXANE NANOAGGREGATES AND USE THEREOF
US 2024016754 A1申请人: FULGENT PHARMA LLC优先权: 2021
US
WO
3 件公开
Oral taxane compositions and methods
US 10835511 B2申请人: ATHENEX HK INNOVATIVE LTD优先权: 2016
US
2 件公开
Crystalline form I of ortataxel
EP 2080763 A1申请人: INDENA SPA优先权: 2008
EP
PHARMACEUTICAL COMPOSITIONS COMPRISING TAXANES
WO 2026164803 A1申请人: WU NIAN优先权: 2025
WO